Lung Neoplasms: all 7,334 studies
Page 54 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic ChemotherapyStatus unknownNCT02121379Not applicable
- Study of the Application of CPAP to Reduce Complications and Improve Lung Cancer Ablation Radiofrequency TreatmentCompletedNCT02117908Not applicable
- Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung CancerTerminatedNCT02117440
- SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC PatientsCompletedNCT02117167Phase 2
- The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells VaccineCompletedNCT02115958Phase 1/2
- Advanced Lung Cancer Treatment With Metformin and Chemo-RadiotherapyTerminatedNCT02115464Phase 2
- Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer PatientsCompletedNCT02113852
- A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsCompletedNCT02113813Phase 1
- A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and TherapyTerminatedNCT02111824Phase 1
- Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLCWithdrawnNCT02109653Phase 2
- Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.CompletedNCT02109549
- A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic AlterationsTerminatedNCT02109016Phase 2
- Photodynamic Therapy During Surgery in Treating Patients With Pleural MalignancyWithdrawnNCT02106559Not applicable
- Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerCompletedNCT02106546Phase 3
- RejuvenAir™ System Lobectomy Safety and Histology StudyCompletedNCT02106143Not applicable
- Identification of Marker of Primary or Acquired Resistance to Anti Tumorous TreatmentStatus unknownNCT02105168Not applicable
- Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor MutationTerminatedNCT02095782Phase 2
- Acupuncture Feasibility Trial for Dyspnea in Lung CancerCompletedNCT02094950Phase 1
- Lung Cancer Detection by Measuring Monocyte ActivityStatus unknownNCT02090166Not applicable
- Feasibility of re Biopsies at ProgressionCompletedNCT02086071Not applicable
- Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem CellsCompletedNCT02084823Phase 1/2
- Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.CompletedNCT02078700Phase 2
- L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid TumoursCompletedNCT02076620Phase 1
- The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）Status unknownNCT02076477Phase 3
- Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung CancerStatus unknownNCT02075957
- Effectiveness of Nursing Case Management for Lung Cancer PatientsCompletedNCT02070497Phase 2
- Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer PatientStatus unknownNCT02069418Phase 2
- Visual Feedback With Optical Sensing - A Feasibility StudyCompletedNCT02068378Not applicable
- Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKIStatus unknownNCT02066870Phase 1
- Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic InsufficiencyStatus unknownNCT02062515Phase 2
- Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLCWithdrawnNCT02059967Phase 1
- Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung CancerWithdrawnNCT02059889Not applicable
- Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT02058433Phase 3
- Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLCCompletedNCT02058056Not applicable
- Neoadjuvant Finasteride for Patients With Non-small Cell Lung CancerTerminatedNCT02055170Phase 2
- Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard ChemotherapyStatus unknownNCT02055144
- Treating NSCLC Minimal Stage IV With Curative IntentTerminatedNCT02054819Phase 2
- Intrapleural Bevacizumab Injection for Malignant Effusion in Lung CancerCompletedNCT02054052Phase 2
- Pilot Study of a Novel Type of CT Scan to Assess Treatment Response During Chemoradiotherapy for Stage III Non-Small Cell Lung CancerCompletedNCT02053285
- Biomarkers for Diagnosis of Lung CancerCompletedNCT02050100
- Study of the Combination of Tivantinib Plus Pemetrexed and CarboplatinCompletedNCT02049060Phase 1/2
- Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)WithdrawnNCT02044601Phase 1/2
- A Prospective Epidemiologic Study of ALK-Positive NSCLC in ChinaCompletedNCT02042105
- Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC PatientsStatus unknownNCT02041468
- PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First ChemotherapyStatus unknownNCT02035683Not applicable
- A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung CancerWithdrawnNCT02034097Phase 2
- Multicentric Study VATS Major Introperative ComplicationsCompletedNCT02031809
- A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung CancerCompletedNCT02031744Phase 3
- Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung CancerStatus unknownNCT02031601Phase 4
- Extensive Staging in Lung CancerTerminatedNCT02030444Not applicable
- Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine CarcinomasWithdrawnNCT02030184Phase 1/2
- RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVERCompletedNCT02029729Phase 1
- Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and CisplatinTerminatedNCT02029690Phase 1
- To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT02029209Phase 2/3
- High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable DiseaseStatus unknownNCT02027090Phase 2
- Iressa Re-challenge in Advanced NSCLC EGFR-mutated PatientsTerminatedNCT02025218Phase 2
- Selumetinib in Combination With Gefitinib in NSCLC PatientsCompletedNCT02025114Phase 1/2
- LC-NMR Study Biomarkers to Detect Lung CancerCompletedNCT02024113
- PALBOCICLIB + PD-0325901 for NSCLC & Solid TumorsCompletedNCT02022982Phase 1
- Magnetic Resonance Imaging (MRI) in MotionCompletedNCT02019199
- Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing ChemoradiationWithdrawnNCT02017925Not applicable
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung CancerStatus unknownNCT02016209Phase 2
- Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerWithdrawnNCT02014545Phase 2
- Single Scope Staging of Lung Cancer With EndosonographyCompletedNCT02014324
- A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02013219Phase 1
- Single Pulmonary Nodule InvestigationStatus unknownNCT02013063
- Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line ChemotherapyTerminatedNCT02011087Not applicable
- Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC PatientsCompletedNCT02010047Not applicable
- Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung CancerStatus unknownNCT02009605Phase 2
- Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerCompletedNCT02009436Phase 1
- Endobronchial Ultrasound Elastography: the Utility of Strain Ratio for Lymph Node Staging in Lung Cancer PatientsCompletedNCT02009319
- Thin Prep Versus Traditional Cytological Procedure for Lung CancerCompletedNCT02007538
- Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLCStatus unknownNCT02005120Phase 2
- Genotyping of Non-small Cell Lung CancerStatus unknownNCT02002117
- Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠBStatus unknownNCT02001168Phase 3
- A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT02000947Phase 1
- Impacts of Exercise on Prognostic Biomarkers in Lung Cancer PatientsCompletedNCT01999881Not applicable
- Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung CancerCompletedNCT01999673Phase 3
- Determinants of Intensity of Care of Lung Cancer Patients With Organ FailureCompletedNCT01999621
- Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung CancerCompletedNCT01998126Phase 1
- Continuation of TKI With or Without Chemotherapy Beyond Gradual ProgressionStatus unknownNCT01998061Phase 2
- Metformin in Stage IV Lung AdenocarcinomaTerminatedNCT01997775Phase 2
- Icotinib Following Chemotherapy Versus Chemotherapy as Adjuvant Therapy in Stage IIA-IIIA NSCLC With EGFR MutationTerminatedNCT01996098Phase 3
- A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung CancerCompletedNCT01995188Phase 1
- Telephone Support Program for Lung Cancer Patients and Their Family CaregiversCompletedNCT01993550Not applicable
- Pilot Study: Utilizing Manometry to Assess Radiation-Induced Changes in Esophageal FunctionTerminatedNCT01992068
- Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)CompletedNCT01991418
- Study of Use of CTC in NSCLCStatus unknownNCT01990651
- Correlation Research of Thioredoxin Reductase in Lung CancerCompletedNCT01985113
- Prophylaxis of Venous Thromboembolism in Advanced Lung CancerStatus unknownNCT01980849Phase 3
- Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer PatientsStatus unknownNCT01980472Phase 2
- Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung CancerCompletedNCT01980212
- Two Different Dosages of Irinotecan Combined With Cisplatin Scheme in Extensive Disease-Small Cell Lung CancerStatus unknownNCT01977235Phase 2
- Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High ExpressionStatus unknownNCT01977209Phase 3
- EBUS/Spectrum AnalysisCompletedNCT01972386
- Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsWithdrawnNCT01971489Phase 1
- Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung CancerStatus unknownNCT01969955Phase 2
- Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer PatientsCompletedNCT01968941Phase 3
- Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung CancerCompletedNCT01967095Phase 1
- A Randomized Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II)CompletedNCT01965223Not applicable